The goal of this case series is to explore whether a talking therapy, specifically Cognitive Behavioural Therapy (CBT) is acceptable and feasible in the management of mood-driven impulsive behaviours in people with bipolar disorder (BD). The main questions it aims to answer are: * Whether CBT Is a feasible intervention for participants with BD who report mood-driven, problematic impulsive behaviours. * Whether CBT for mood-driven, problematic impulsive behaviours (CBT-PIB) is acceptable to service users with BD and therapists. * Whether clinical outcomes are consistent with the potential for this novel intervention to offer clinical benefit to participants with BD. The study also hopes to: * conduct a preliminary examination of the safety of CBT-PIB and the research procedures. * gather information on the potential mechanisms of action of CBT-PIB and, * gather information on the types of mood-driven impulsive behaviours individuals with BD may seek support for. Participants will: * be offered up to 12 individual sessions of CBT focusing on mood-driven impulsive behaviours. * be asked to complete a battery of self-report measures (5) when they enter the study and at the start and end of treatment. * be asked to track mood and impulsive behaviours by completing a brief set of measures (3) weekly during the two-week baseline phase, the intervention phase and the 2-week post-intervention phase. * be asked to complete a survey on the acceptability of the intervention and * be invited to an optional semi-structured interview on their research experience.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Up to 12 sessions of Cognitive Behavioural Therapy adapted to focus on mood-driven impulsivity in adults with bipolar disorder.
AccEPT Clinic
Exeter, Devon, United Kingdom
Overall acceptability and feasibility of the CBT protocol measured by the Client Satisfaction Questionnaire CBT-PIB
qualitative and quantitative feedback from participants
Time frame: Post-intervention at week 16
rates of clinically significant and reliable change in mood measured by the Patient health questionnaire (PHQ-9)
used to monitor the severity of depression and response to treatment
Time frame: Through study completion, an average of 18 weeks
rates of clinically significant and reliable change in symptoms of mania measured by the Altman Self-Rating Mania Scale
scale that assesses the presence and severity of manic or hypomanic symptoms
Time frame: Through study completion, an average of 18 weeks
Changes in management of impulsivity measured by the Visual Analogue Scale
Visual scale measuring the severity and impact of general and behavioural impulsivity
Time frame: Through study completion, an average of 18 weeks
Number of participants with intervention-related adverse events assessed by the adverse events form
qualitative form eliciting adverse events
Time frame: Through study completion, an average of 18 weeks
rates of clinically significant and reliable change in general daily functioning as measured by the Work and Social Adjustment Scale
scale assesses changes in the impact of a person's mental health difficulties on their ability to function in terms of work, home management, social leisure, private leisure and personal or family relationships.
Time frame: At baseline, 2 weeks and 14 weeks
rates of clinically significant and reliable change in quality of life as measured by the Brief Quality of Life in Bipolar Disorder
self-report measure of changes in disorder-specific quality of life
Time frame: At baseline, 2 weeks and 14 weeks
rates of clinically significant and reliable change in symptoms of anxiety as measured by the General Anxiety Disorder Assessment (GAD7)
scale measuring changes in symptoms of anxiety
Time frame: At baseline, in 2 weeks and in 14 weeks
rates of clinically significant and reliable change in overall wellbeing as measured by the Warwick-Edinburgh Mental Well-being Scale
scale measuring changes in positive features of mental health
Time frame: At baseline, in 2 weeks and in 14 weeks
rates of clinically significant and reliable change in impulsivity measured by the Short Urgency, Premeditation (lack of), Perseverance (lack of), Sensation Seeking, Positive Urgency, Impulsive Behavior Scale
Scale measuring changes in 5 domains of impulsive behaviour
Time frame: At baseline, in 2 weeks and in 14 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.